ASLN - ASLAN Pharmaceuticals Limited

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5141.39M
Enterprise value 3967.57M
Trailing P/E N/A
Forward P/E 1-4.59
PEG Ratio (5 yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)15.45
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6-21.41

Financial highlights

Currency in TWD.

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)30 Sep 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-47.34%
Return on equity (ttm)-99.00%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -45.2M
Net income avi to common (ttm)-45.26M
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.8M
Total cash per share (mrq)0.22
Total debt (mrq)9.79M
Total debt/equity (mrq)23.43
Current ratio (mrq)5.19
Book value per share (mrq)0.33

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A

Trading information

Stock price history

Beta (3Y monthly) N/A
52-week change 3∞%
S&P500 52-week change 34.76%
52-week high 310.44
52-week low 35.00
50-day moving average 36.60
200-day moving average 37.51

Share statistics

Avg vol (3-month) 33.15k
Avg vol (10-day) 32.42k
Shares outstanding 5160.13M
Float 114.18M
% held by insiders 10.00%
% held by institutions 110.92%
Shares short (31 Oct 2018) 41.27k
Short ratio (31 Oct 2018) 40.42
Short % of float (31 Oct 2018) 4N/A
Short % of shares outstanding (31 Oct 2018) 40.00%
Shares short (prior month 28 Sep 2018) 4826

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 2N/A
Last split date 3N/A